TWD 32.25
(-0.77%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 96.89 Million TWD | -15.07% |
2022 | 114.08 Million TWD | 18.0% |
2021 | 96.68 Million TWD | 57.04% |
2020 | 61.56 Million TWD | 20.34% |
2019 | 51.16 Million TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 88.36 Million TWD | -0.4% |
2024 Q1 | 88.72 Million TWD | -8.43% |
2023 FY | 96.89 Million TWD | -15.07% |
2023 Q2 | 93.84 Million TWD | -1.14% |
2023 Q1 | 94.92 Million TWD | -15.55% |
2023 Q3 | 93.12 Million TWD | -0.77% |
2023 Q4 | 96.89 Million TWD | 4.05% |
2022 Q3 | 92.82 Million TWD | 0.0% |
2022 Q4 | 112.4 Million TWD | 21.1% |
Name | Total Debt | Total Debt Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 75.943% |
Level Biotechnology Inc. | 13.5 Million TWD | -617.605% |
Sagittarius Life Science Corp | 13.32 Million TWD | -627.246% |
GeneReach Biotechnology Corp. | 257.03 Million TWD | 62.305% |
Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 65.837% |
Visgeneer Inc. | 158.6 Million TWD | 38.911% |
Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 44.344% |
G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -1684.036% |
Neith Corporation | 3.54 Million TWD | -2636.261% |
TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -8174.21% |
Enimmune corporation | 45.73 Million TWD | -111.858% |
TaiRx, Inc. | 12.28 Million TWD | -688.629% |
EirGenix Inc. | 465.16 Million TWD | 79.171% |
BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | -66.462% |
Sunny Pharmtech Inc. | 391.42 Million TWD | 75.247% |
Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -11036.897% |
BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | -640.078% |
Feng Chi Biotech Corp. | 10.79 Million TWD | -797.305% |
Lukas Biomedical Inc. | 82.55 Million TWD | -17.365% |
RBC Bioscience Corporation | 487.36 Million TWD | 80.119% |
BiOptic Inc. | 93.19 Million TWD | -3.963% |
Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -6905.857% |
Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -17909.48% |
Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | -574.024% |
Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 85.788% |
Mycenax Biotech Inc. | 726.27 Million TWD | 86.659% |
Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 95.093% |
Bio Preventive Medicine Corp. | 113.44 Million TWD | 14.594% |
TaiMed Biologics Inc. | 750.85 Million TWD | 87.096% |
GlycoNex Incorporation | 900 Thousand TWD | -10665.667% |
Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 69.734% |
SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -4483.302% |
Lin BioScience, Inc. | 42.87 Million TWD | -125.995% |
BRIM Biotechnology, Inc. | 3.59 Million TWD | -2597.411% |
VBI | - TWD | -Infinity% |
CHO Pharma, Inc. | - TWD | -Infinity% |
NaviFUS Corp. | 32.69 Million TWD | -196.366% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 76.766% |
Sinew Pharma Inc. | 6.46 Million TWD | -1398.933% |
Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | -257.255% |
Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 50.6% |
Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | -668.366% |
AP Biosciences Inc | 82.07 Million TWD | -18.046% |
Medigen Biotechnology Corp. | 2.91 Billion TWD | 96.672% |
3D Global Biotech Inc. | 10.37 Million TWD | -833.529% |
Pharmosa Biopharm Inc. | 144.36 Million TWD | 32.887% |
Intech Biopharm Corporation | 1.43 Billion TWD | 93.248% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 75.652% |
Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -2125.333% |
TWi Biotechnology, Inc. | 7.97 Million TWD | -1115.544% |
Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -1542.777% |
TCI GENE Inc. | 6.79 Million TWD | -1325.916% |
MegaPro Biomedical Co., Ltd | 8.31 Million TWD | -1064.835% |
Senhwa Biosciences, Inc. | 9.6 Million TWD | -909.176% |
Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 63.93% |
NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | -807.049% |
PharmaEngine, Inc. | 14.8 Million TWD | -554.271% |
Savior Lifetec Corporation | 270.37 Million TWD | 64.164% |
TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | -29.729% |
OBI Pharma, Inc. | 501.05 Million TWD | 80.663% |
Meribank Biotech Co., Ltd | 34.03 Million TWD | -184.647% |
Acepodia, Inc. | 273.81 Million TWD | 64.614% |
Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | -373.609% |